Floatz logo

342 assets in Glioblastoma

Therapeutic assets addressing Glioblastoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Arm 4: Il13Ra2-Specific Car Tcm Cells
Glioblastoma
City of Hope Medical CenterP1CC (41)
Autologous Anti-Cd19 Car-Expressing T Lymphocytes
Glioblastoma
City of Hope Medical CenterP1CC (41)
Autologous Cd1C+ /Cd141+ Mydc
Glioblastoma
Universitair Ziekenhuis BrusselP1/2CC (41)
Autologous Γδt Cells
Glioblastoma
In8bio Inc.P1/2CC (41)
Avotaciclib
Glioblastoma
BeyondBio Inc.P1CC (41)
Bicalutamide
Glioblastoma
University of NebraskaP1CC (41)
Car.B7-H3T Cells Infusion
Glioblastoma
UNC Lineberger Comprehensive Cancer CenterP1CC (41)
Carboxylesterase-Expressing Allogeneic Neural Stem Cells
Glioblastoma
City of Hope Medical CenterP1CC (41)
Chlorotoxin -Cd28-Cd3Zeta-Cd19T-Expressing Car T-Lymphocytes
Glioblastoma
City of Hope Medical CenterP1CC (41)
Ctx-009
Glioblastoma
Washington University School of MedicineP1/2CC (41)
Ctx-471
Glioblastoma
Washington University School of MedicineP1/2CC (41)
Cue-102
Glioblastoma
David Reardon, MDP1CC (41)
Daratumumab
Glioblastoma
West Virginia UniversityP1/2CC (41)
Dendritic Cell Tumor Cell Lysate Vaccine
Glioblastoma
Jonsson Comprehensive Cancer CenterP1CC (41)
Dual-Target Antigen-Selected Car-Nk
Glioblastoma
Essen BiotechP1/2CC (41)
Ebnk-001
Glioblastoma
Essen BiotechP1/2CC (41)
Eb-Select Single-Target Car-Nk Cells
Glioblastoma
Essen BiotechP1/2CC (41)
Ex-Vivo Expanded Autologous Il-8 Receptor Modified Cd70 Car T Cells
Glioblastoma
University of FloridaP1CC (41)
Fz-Ad005
Glioblastoma
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.P1CC (41)
Gabapentin
Glioblastoma
University of ZurichP1/2CC (41)
Ino-5401
Glioblastoma
Inovio PharmaceuticalsP1/2CC (41)
Ino 9012
Glioblastoma
Inovio PharmaceuticalsP1/2CC (41)
Interleukin-15
Glioblastoma
Essen BiotechP1/2CC (41)
Inverse Correlated Dual-Target, Truncated Il7Ra Modified Car -Expressing Autologous T-Lymphocytes.
Glioblastoma
Beijing Tiantan HospitalP1CC (41)
Ivonescimab
Glioblastoma
M.D. Anderson Cancer CenterP1/2CC (41)
mt-125
Glioblastoma
Myosin Therapeutics Inc.P1/2CC (41)
MTX110
Glioblastoma
Biodexa PharmaceuticalsP1CC (41)
Nadravaleucel
Glioblastoma
M.D. Anderson Cancer CenterP1CC (41)
ngm707
Glioblastoma
NGM Biopharmaceuticals, IncP1/2CC (41)
Nms-03305293
Glioblastoma
Nerviano Medical SciencesP1/2CC (41)
Olaptesed Pegol
Glioblastoma
TME Pharma AGP1/2CC (41)
Oncolytic Adenovirus Ad5-Dnx-2401
Glioblastoma
M.D. Anderson Cancer CenterP1CC (41)
Phox430
Glioblastoma
Phost'In TherapeuticsP1CC (41)
Pitavastatin
Glioblastoma
C.DirvenEarly P1CC (41)
rz-001
Glioblastoma
Rznomics, Inc.P1/2CC (41)
S-Gboxin
Glioblastoma
Petrov, AndreyP1CC (41)
st101
Glioblastoma
Sapience TherapeuticsP1/2CC (41)
ts-2021
Glioblastoma
Beijing Neurosurgical InstituteP1CC (41)
Verteporfin
Glioblastoma
Emory UniversityP1/2CC (41)
vrt106
Glioblastoma
Guangzhou Virotech Pharmaceutical Co., Ltd.P1/2CC (41)
asp8374
Glioblastoma
Dana-Farber Cancer InstituteP1CC (40)
bi 907828
Glioblastoma
Boehringer IngelheimP1CC (40)
CV09050101 mRNA vaccine
Glioblastoma
CureVacP1CC (40)
G 207
Glioblastoma
M.D. Anderson Cancer CenterP1CC (40)
Iti-1001
Glioblastoma
Immunomic Therapeutics, Inc.P1CC (40)
Neoantigen Dna Vaccine
Glioblastoma
Washington University School of MedicineP1CC (40)
Polyethyleneglycol-7-Ethyl-10-Hydroxycamptothecin Dfp-13318
Glioblastoma
National Cancer Institute (NCI)P1/2CC (40)
prt3645
Glioblastoma
Prelude TherapeuticsP1CC (40)
ro7428731
Glioblastoma
Hoffmann-La RocheP1CC (40)
Sotigalimab
Glioblastoma
Pediatric Brain Tumor ConsortiumP1CC (40)
Showing 201 to 250 of 342 assets
PreviousPage 5 of 7Next